Back to 1A 1832 Asset Management L.P.
CRDL3 quarters
Position history for 1A1832 Asset Management L.P.'s holdings in CARDIOL THERAPEUTICS INC
Yes. 1832 Asset Management holds 100,000 shares of CRDL (Cardiol Therapeutics), worth $106,000, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. 1832 Asset Management has held CRDL since Q4 2025, across 3 quarterly 13F filings.
Current Value
$106,000
Current Shares
100,000
Total Value Change
+$10,620
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CRDL: Mirae Asset Global Investments Co., Ltd., CITADEL ADVISORS LLC